Lucy McParland

1.7k total citations · 2 hit papers
28 papers, 999 citations indexed

About

Lucy McParland is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, Lucy McParland has authored 28 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 7 papers in Surgery. Recurrent topics in Lucy McParland's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Colorectal and Anal Carcinomas (6 papers). Lucy McParland is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Colorectal and Anal Carcinomas (6 papers). Lucy McParland collaborates with scholars based in United Kingdom, United States and Japan. Lucy McParland's co-authors include Laura C. Coates, Anna R. Moverley, Paul Emery, Philip G. Conaghan, Philip Helliwell, Nuria Navarro-Coy, John O’Dwyer, Sarah Brown, David Meads and Walter M. Gregory and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Lucy McParland

28 papers receiving 987 citations

Hit Papers

Effect of tight control of inflammation in early psoriati... 2015 2026 2018 2022 2015 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
    2015 329 citations Laura C. Coates, Anna R. Moverley et al. The Lancet profile →
  2. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
    2021 152 citations Kate Absolom, Lorraine Warrington et al. Journal of Clinical Oncology profile →

Peers

Lucy McParland
Antoine G. Sreih United States
Andrea Shapiro United States
Kjell Bergfeldt Sweden
Sonja Burgstaller Austria
Luís Casanova Peru
Claudia Vener Italy
Dariusz Wydra Poland
Andrew Dagis United States
Jeff H. Lipton Canada
Merlın Hamre United States
Antoine G. Sreih United States
Lucy McParland
Citations per year, relative to Lucy McParland Lucy McParland (= 1×) peers Antoine G. Sreih

Countries citing papers authored by Lucy McParland

Since Specialization
Citations

This map shows the geographic impact of Lucy McParland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy McParland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy McParland more than expected).

Fields of papers citing papers by Lucy McParland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy McParland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy McParland. The network helps show where Lucy McParland may publish in the future.

Co-authorship network of co-authors of Lucy McParland

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy McParland. A scholar is included among the top collaborators of Lucy McParland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy McParland. Lucy McParland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Absolom, Kate, Lorraine Warrington, Jenny Hewison, et al.. (2021). Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology. 39(7). 734–747. 152 indexed citations breakdown →
2.
Gilbert, Alexandra, K. Drinkwater, Lucy McParland, et al.. (2020). UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes. European Journal of Cancer. 128. 7–16. 25 indexed citations
3.
McParland, Lucy, et al.. (2019). Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy. Clinical and Translational Radiation Oncology. 19. 17–26. 10 indexed citations
4.
Gilbert, Alexandra, Lucy McParland, Sue Bell, et al.. (2019). Pre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACT5). Annals of Oncology. 30. v203–v204. 3 indexed citations
5.
Franks, K., Lucy McParland, David Baldwin, et al.. (2018). P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery. Journal of Thoracic Oncology. 13(10). S837–S837. 1 indexed citations
6.
O’Dwyer, John, David Meads, Claire Hulme, et al.. (2017). Cost‐Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. Arthritis Care & Research. 70(3). 462–468. 10 indexed citations
7.
Howard, Dena, Talha Munir, Lucy McParland, et al.. (2017). Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials. 18(1). 387–387. 25 indexed citations
8.
Howard, Dena, Talha Munir, Lucy McParland, et al.. (2017). Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL. Leukemia. 31(11). 2416–2425. 21 indexed citations
9.
Franks, K., M. Snee, Babu Naidu, et al.. (2017). P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery. Journal of Thoracic Oncology. 12(1). S631–S632. 1 indexed citations
10.
Teo, Mark, Lucy McParland, Ane Appelt, & David Sebag‐Montefiore. (2017). Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics. 100(1). 146–158. 11 indexed citations
11.
Munir, Talha, Dena Howard, Lucy McParland, et al.. (2017). Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL. Leukemia. 31(10). 2085–2093. 20 indexed citations
12.
Zekri, Jamal, et al.. (2017). Complications of bone metastases from malignant melanoma. Journal of bone oncology. 8. 13–17. 23 indexed citations
13.
Howard, Dena, Anna Hockaday, Talha Munir, et al.. (2017). GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial. Trials. 18(1). 353–353. 3 indexed citations
14.
15.
Rawstron, Andy C., Dena Howard, Lucy McParland, et al.. (2016). Compartment Effect on the Prognostic Significance of MRD Detection in CLL: Impact of Treatment Type and Duration of Follow-up. Blood. 128(22). 3226–3226. 8 indexed citations
16.
Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2015). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. The Lancet. 386(10012). 2489–2498. 329 indexed citations breakdown →
17.
Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2014). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial. The Lancet. 383. S36–S36. 11 indexed citations
18.
Coates, Laura C., Nuria Navarro-Coy, Sarah Brown, et al.. (2013). The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders. 14(1). 101–101. 76 indexed citations
19.
20.
Woodward, Emma R., Satinder Jagdev, Lucy McParland, et al.. (2010). Skeletal complications and survival in renal cancer patients with bone metastases. Bone. 48(1). 160–166. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine G. Sreih Breakdown of academic impact, for papers by Andrea Shapiro Breakdown of academic impact, for papers by Kjell Bergfeldt Breakdown of academic impact, for papers by Sonja Burgstaller Breakdown of academic impact, for papers by Luís Casanova Breakdown of academic impact, for papers by Claudia Vener Breakdown of academic impact, for papers by Dariusz Wydra Breakdown of academic impact, for papers by Andrew Dagis Breakdown of academic impact, for papers by Jeff H. Lipton Breakdown of academic impact, for papers by Merlın Hamre
Rankless by CCL
2026